Literature DB >> 18438118

Histological grading of colorectal cancer: a simple and objective method.

Hideki Ueno1, Hidetaka Mochizuki, Yojiro Hashiguchi, Megumi Ishiguro, Yoshiki Kajiwara, Taichi Sato, Hideyuki Shimazaki, Kazuo Hase, Ian C Talbot.   

Abstract

OBJECTIVE: Tumor grade employed for colorectal cancer has long been based on the degree of differentiation, which is difficult to judge objectively. The aim of this study was to determine whether the extent of the poorly differentiated component (POR) could be a valuable criterion for a grading system. PATIENTS AND METHODS: A total of 1075 patients with advanced colorectal cancer were pathologically reviewed. POR was newly defined as a region in which a cancer has no glandular formation, irrespective of a mucin-producing or invasive pattern, and we quantitatively classified the POR into 6 degrees using the microscopic field of an objective lens as a standard.
RESULTS: Survival analyses of the extent of POR demonstrated that a 3-category grading system provides the most efficient survival stratification. Grade III was applied to tumors (n = 339) for which the POR fully occupied the microscopic field of a 40x objective lens. For tumors having a smaller POR, cancer clusters without a gland structure composed of > or = 5 cancer cells ("clusters") were counted in the microscopic field of a 4x objective lens, where "clusters" were observed most intensively. Tumors with < 10 "clusters" were classified as grade I (n = 161), and those with > or = 10 "clusters" as grade II (n = 575). Patients classified as grade I demonstrated a very favorable prognosis, with a 99.3% cancer-related 5-year survival rate, whereas the survival was 86.0% for grade II and 68.9% for grade III (P < 0.0001 in each group). Multivariate analysis demonstrated that the grades of POR function as an independent prognosticator, as do T-stage and N-stage.
CONCLUSIONS: The grading system utilizing POR is distinctive in terms of the simplicity of judgment based on its quantification and the ability to determine which patients will likely be cured by surgery alone. It will aid in selecting postoperative treatment strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18438118     DOI: 10.1097/SLA.0b013e318167580f

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  18 in total

1.  The Impact of Tumor Differentiation on the Prognosis of HBV-Associated Solitary Hepatocellular Carcinoma Following Hepatectomy: A Propensity Score Matching Analysis.

Authors:  Junyi Shen; Jiaye Liu; Chuan Li; Tianfu Wen; Lvnan Yan; Jiayin Yang
Journal:  Dig Dis Sci       Date:  2018-05-07       Impact factor: 3.199

2.  C-reactive protein concentration is associated with prognosis in patients suffering from peritoneal carcinomatosis of colorectal origin.

Authors:  Marcel C G van de Poll; Yvonne L B Klaver; Valery E P P Lemmens; Bart J M Leenders; Simon W Nienhuijs; Ignace H J T de Hingh
Journal:  Int J Colorectal Dis       Date:  2011-04-08       Impact factor: 2.571

3.  Clinical significance of immunohistochemical lymphovascular evaluation to determine additional surgery after endoscopic submucosal dissection for colorectal T1 carcinoma.

Authors:  Tomoyuki Nishimura; Shiro Oka; Shinji Tanaka; Naoki Asayama; Shinji Nagata; Yuzuru Tamaru; Toshio Kuwai; Ken Yamashita; Yuki Ninomiya; Yasuhiko Kitadai; Koji Arihiro; Kazuya Kuraoka; Mayumi Kaneko; Fumio Shimamoto; Kazuaki Chayama
Journal:  Int J Colorectal Dis       Date:  2020-11-04       Impact factor: 2.571

4.  PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system.

Authors:  Ishaan C Jagan; Ravi K Deevi; Aliya Fatehullah; Rebecca Topley; Joshua Eves; Michael Stevenson; Maurice Loughrey; Kenneth Arthur; Frederick Charles Campbell
Journal:  Neoplasia       Date:  2013-11       Impact factor: 5.715

5.  In hepatocellular carcinomas, any proportion of poorly differentiated components is associated with poor prognosis after hepatectomy.

Authors:  Kazunari Sasaki; Masamichi Matsuda; Yu Ohkura; Yusuke Kawamura; Masafumi Inoue; Masaji Hashimoto; Kenji Ikeda; Hiromitsu Kumada; Goro Watanabe
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

6.  Study protocol of the SACURA trial: a randomized phase III trial of efficacy and safety of UFT as adjuvant chemotherapy for stage II colon cancer.

Authors:  Megumi Ishiguro; Hidetaka Mochizuki; Naohiro Tomita; Yasuhiro Shimada; Keiichi Takahashi; Kenjiro Kotake; Masahiko Watanabe; Yukihide Kanemitsu; Hideki Ueno; Toshiaki Ishikawa; Hiroyuki Uetake; Shigeyuki Matsui; Satoshi Teramukai; Kenichi Sugihara
Journal:  BMC Cancer       Date:  2012-07-07       Impact factor: 4.430

7.  Poorly differentiated clusters with larger extents have a greater impact on survival: a semi-quantitative pathological evaluation for 239 patients with non-mucinous pT2-3 colorectal carcinoma.

Authors:  Osamu Kinoshita; Mitsuo Kishimoto; Yasutoshi Murayama; Satoru Yasukawa; Eiichi Konishi; Eigo Otsuji; Akio Yanagisawa
Journal:  World J Surg Oncol       Date:  2015-04-08       Impact factor: 2.754

8.  Poorly Differentiated Clusters in Colorectal Adenocarcinomas Share Biological Similarities with Micropapillary Patterns as well as Tumor Buds.

Authors:  Mineui Hong; Jeong Won Kim; Mi Kyung Shin; Byung Chun Kim
Journal:  J Korean Med Sci       Date:  2017-10       Impact factor: 2.153

9.  Five-point scoring system based on clinicopathological data: A convenient criterion to determine prognosis of patients with colorectal carcinoma.

Authors:  Tadahiro Nozoe; Mayuko Kohno; Tomohiro Iguchi; Takashi Maeda; Takahiro Ezaki
Journal:  Oncol Lett       Date:  2013-01-08       Impact factor: 2.967

10.  Prognostic value of poorly differentiated clusters in invasive breast cancer.

Authors:  Ying Sun; Fenli Liang; Wei Cao; Kai Wang; Jianjun He; Hongyan Wang; Yili Wang
Journal:  World J Surg Oncol       Date:  2014-10-12       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.